nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Temozolomide—skin cancer	0.106	0.292	CbGbCtD
Brinzolamide—CYP3A4—Imiquimod—skin cancer	0.106	0.292	CbGbCtD
Brinzolamide—CYP3A4—Vismodegib—skin cancer	0.0735	0.202	CbGbCtD
Brinzolamide—CYP3A4—Vemurafenib—skin cancer	0.0581	0.16	CbGbCtD
Brinzolamide—CA6—ear—skin cancer	0.0221	0.189	CbGeAlD
Brinzolamide—CYP3A4—Docetaxel—skin cancer	0.0199	0.0548	CbGbCtD
Brinzolamide—CA6—hair follicle—skin cancer	0.0116	0.0996	CbGeAlD
Brinzolamide—CA1—nerve—skin cancer	0.00738	0.0632	CbGeAlD
Brinzolamide—CA5A—female reproductive system—skin cancer	0.00612	0.0524	CbGeAlD
Brinzolamide—CA4—nerve—skin cancer	0.00577	0.0494	CbGeAlD
Brinzolamide—CA2—hair follicle—skin cancer	0.00401	0.0343	CbGeAlD
Brinzolamide—CA12—connective tissue—skin cancer	0.00375	0.0321	CbGeAlD
Brinzolamide—CA9—female reproductive system—skin cancer	0.00358	0.0306	CbGeAlD
Brinzolamide—CA6—head—skin cancer	0.0033	0.0282	CbGeAlD
Brinzolamide—CA4—nipple—skin cancer	0.00328	0.0281	CbGeAlD
Brinzolamide—CA4—neck—skin cancer	0.00324	0.0278	CbGeAlD
Brinzolamide—CA5B—mammalian vulva—skin cancer	0.00277	0.0237	CbGeAlD
Brinzolamide—CA2—nipple—skin cancer	0.00272	0.0233	CbGeAlD
Brinzolamide—CA2—neck—skin cancer	0.00269	0.023	CbGeAlD
Brinzolamide—CA12—female reproductive system—skin cancer	0.00265	0.0227	CbGeAlD
Brinzolamide—CA5B—female reproductive system—skin cancer	0.00237	0.0203	CbGeAlD
Brinzolamide—CA12—head—skin cancer	0.00221	0.0189	CbGeAlD
Brinzolamide—CA1—lymphoid tissue—skin cancer	0.00217	0.0186	CbGeAlD
Brinzolamide—CA1—female reproductive system—skin cancer	0.0021	0.018	CbGeAlD
Brinzolamide—CA5B—head—skin cancer	0.00198	0.017	CbGeAlD
Brinzolamide—CA2—connective tissue—skin cancer	0.00193	0.0165	CbGeAlD
Brinzolamide—CA2—epithelium—skin cancer	0.00183	0.0157	CbGeAlD
Brinzolamide—CA1—head—skin cancer	0.00175	0.015	CbGeAlD
Brinzolamide—CA2—skin of body—skin cancer	0.00174	0.0149	CbGeAlD
Brinzolamide—CA4—female reproductive system—skin cancer	0.00164	0.014	CbGeAlD
Brinzolamide—CA2—mammalian vulva—skin cancer	0.00159	0.0136	CbGeAlD
Brinzolamide—CA2—lymphoid tissue—skin cancer	0.00141	0.0121	CbGeAlD
Brinzolamide—CA5B—lymph node—skin cancer	0.00139	0.0119	CbGeAlD
Brinzolamide—CA4—head—skin cancer	0.00137	0.0117	CbGeAlD
Brinzolamide—CA2—female reproductive system—skin cancer	0.00136	0.0116	CbGeAlD
Brinzolamide—CA1—lymph node—skin cancer	0.00123	0.0105	CbGeAlD
Brinzolamide—CA2—head—skin cancer	0.00113	0.00972	CbGeAlD
Brinzolamide—Nervous system disorder—Imiquimod—skin cancer	0.00112	0.00215	CcSEcCtD
Brinzolamide—Tachycardia—Imiquimod—skin cancer	0.00111	0.00214	CcSEcCtD
Brinzolamide—Pollakiuria—Temozolomide—skin cancer	0.00111	0.00213	CcSEcCtD
Brinzolamide—Skin disorder—Imiquimod—skin cancer	0.00111	0.00213	CcSEcCtD
Brinzolamide—Erectile dysfunction—Temozolomide—skin cancer	0.00111	0.00213	CcSEcCtD
Brinzolamide—Angina pectoris—Fluorouracil—skin cancer	0.00108	0.00207	CcSEcCtD
Brinzolamide—Infestation NOS—Temozolomide—skin cancer	0.00107	0.00206	CcSEcCtD
Brinzolamide—Infestation—Temozolomide—skin cancer	0.00107	0.00206	CcSEcCtD
Brinzolamide—Depression—Temozolomide—skin cancer	0.00107	0.00205	CcSEcCtD
Brinzolamide—Pharyngitis—Dactinomycin—skin cancer	0.00105	0.00203	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00104	0.002	CcSEcCtD
Brinzolamide—Insomnia—Imiquimod—skin cancer	0.00103	0.00198	CcSEcCtD
Brinzolamide—Paraesthesia—Imiquimod—skin cancer	0.00102	0.00197	CcSEcCtD
Brinzolamide—Dyspnoea—Imiquimod—skin cancer	0.00102	0.00195	CcSEcCtD
Brinzolamide—Somnolence—Imiquimod—skin cancer	0.00101	0.00195	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Temozolomide—skin cancer	0.00101	0.00195	CcSEcCtD
Brinzolamide—Alopecia—Bleomycin—skin cancer	0.00101	0.00194	CcSEcCtD
Brinzolamide—Sinusitis—Temozolomide—skin cancer	0.001	0.00193	CcSEcCtD
Brinzolamide—Dyspepsia—Imiquimod—skin cancer	0.001	0.00193	CcSEcCtD
Brinzolamide—Erythema—Bleomycin—skin cancer	0.000991	0.00191	CcSEcCtD
Brinzolamide—Decreased appetite—Imiquimod—skin cancer	0.00099	0.00191	CcSEcCtD
Brinzolamide—Infestation NOS—Fluorouracil—skin cancer	0.000986	0.0019	CcSEcCtD
Brinzolamide—Infestation—Fluorouracil—skin cancer	0.000986	0.0019	CcSEcCtD
Brinzolamide—Hypersensitivity—Vemurafenib—skin cancer	0.000984	0.00189	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Imiquimod—skin cancer	0.000983	0.00189	CcSEcCtD
Brinzolamide—Fatigue—Imiquimod—skin cancer	0.000982	0.00189	CcSEcCtD
Brinzolamide—Visual disturbance—Docetaxel—skin cancer	0.000974	0.00188	CcSEcCtD
Brinzolamide—Pain—Imiquimod—skin cancer	0.000974	0.00187	CcSEcCtD
Brinzolamide—Conjunctivitis—Fluorouracil—skin cancer	0.000958	0.00184	CcSEcCtD
Brinzolamide—CA4—lymph node—skin cancer	0.000958	0.00821	CbGeAlD
Brinzolamide—Asthenia—Vemurafenib—skin cancer	0.000958	0.00184	CcSEcCtD
Brinzolamide—Hypoaesthesia—Temozolomide—skin cancer	0.000956	0.00184	CcSEcCtD
Brinzolamide—Pharyngitis—Temozolomide—skin cancer	0.000953	0.00184	CcSEcCtD
Brinzolamide—Urinary tract disorder—Temozolomide—skin cancer	0.000949	0.00183	CcSEcCtD
Brinzolamide—Oedema peripheral—Temozolomide—skin cancer	0.000946	0.00182	CcSEcCtD
Brinzolamide—Pruritus—Vemurafenib—skin cancer	0.000945	0.00182	CcSEcCtD
Brinzolamide—Connective tissue disorder—Temozolomide—skin cancer	0.000944	0.00182	CcSEcCtD
Brinzolamide—Urethral disorder—Temozolomide—skin cancer	0.000942	0.00181	CcSEcCtD
Brinzolamide—Alopecia—Dactinomycin—skin cancer	0.000939	0.00181	CcSEcCtD
Brinzolamide—Feeling abnormal—Imiquimod—skin cancer	0.000938	0.00181	CcSEcCtD
Brinzolamide—Epistaxis—Fluorouracil—skin cancer	0.00093	0.00179	CcSEcCtD
Brinzolamide—Visual impairment—Temozolomide—skin cancer	0.000926	0.00178	CcSEcCtD
Brinzolamide—Sinusitis—Fluorouracil—skin cancer	0.000925	0.00178	CcSEcCtD
Brinzolamide—Erythema—Dactinomycin—skin cancer	0.000925	0.00178	CcSEcCtD
Brinzolamide—Pain in extremity—Docetaxel—skin cancer	0.000923	0.00178	CcSEcCtD
Brinzolamide—Ill-defined disorder—Bleomycin—skin cancer	0.00092	0.00177	CcSEcCtD
Brinzolamide—Diarrhoea—Vemurafenib—skin cancer	0.000914	0.00176	CcSEcCtD
Brinzolamide—Urticaria—Imiquimod—skin cancer	0.000905	0.00174	CcSEcCtD
Brinzolamide—Eye disorder—Temozolomide—skin cancer	0.000898	0.00173	CcSEcCtD
Brinzolamide—Tinnitus—Temozolomide—skin cancer	0.000896	0.00172	CcSEcCtD
Brinzolamide—Malaise—Bleomycin—skin cancer	0.000894	0.00172	CcSEcCtD
Brinzolamide—Cardiac disorder—Temozolomide—skin cancer	0.000892	0.00172	CcSEcCtD
Brinzolamide—Rhinitis—Fluorouracil—skin cancer	0.000887	0.00171	CcSEcCtD
Brinzolamide—Dizziness—Vemurafenib—skin cancer	0.000883	0.0017	CcSEcCtD
Brinzolamide—Hypoaesthesia—Fluorouracil—skin cancer	0.000881	0.0017	CcSEcCtD
Brinzolamide—Pharyngitis—Fluorouracil—skin cancer	0.000878	0.00169	CcSEcCtD
Brinzolamide—CYP3A4—female reproductive system—skin cancer	0.000876	0.00751	CbGeAlD
Brinzolamide—Angiopathy—Temozolomide—skin cancer	0.000872	0.00168	CcSEcCtD
Brinzolamide—Immune system disorder—Temozolomide—skin cancer	0.000868	0.00167	CcSEcCtD
Brinzolamide—Mediastinal disorder—Temozolomide—skin cancer	0.000866	0.00167	CcSEcCtD
Brinzolamide—Cough—Bleomycin—skin cancer	0.000865	0.00167	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dactinomycin—skin cancer	0.000858	0.00165	CcSEcCtD
Brinzolamide—Liver function test abnormal—Docetaxel—skin cancer	0.000853	0.00164	CcSEcCtD
Brinzolamide—Vomiting—Vemurafenib—skin cancer	0.000849	0.00163	CcSEcCtD
Brinzolamide—Alopecia—Temozolomide—skin cancer	0.000849	0.00163	CcSEcCtD
Brinzolamide—Chest pain—Bleomycin—skin cancer	0.000844	0.00162	CcSEcCtD
Brinzolamide—Myalgia—Bleomycin—skin cancer	0.000844	0.00162	CcSEcCtD
Brinzolamide—Abdominal pain upper—Docetaxel—skin cancer	0.000843	0.00162	CcSEcCtD
Brinzolamide—Rash—Vemurafenib—skin cancer	0.000842	0.00162	CcSEcCtD
Brinzolamide—Mental disorder—Temozolomide—skin cancer	0.000842	0.00162	CcSEcCtD
Brinzolamide—Dermatitis—Vemurafenib—skin cancer	0.000841	0.00162	CcSEcCtD
Brinzolamide—Hypersensitivity—Imiquimod—skin cancer	0.000839	0.00162	CcSEcCtD
Brinzolamide—Headache—Vemurafenib—skin cancer	0.000837	0.00161	CcSEcCtD
Brinzolamide—Erythema—Temozolomide—skin cancer	0.000836	0.00161	CcSEcCtD
Brinzolamide—Malnutrition—Temozolomide—skin cancer	0.000836	0.00161	CcSEcCtD
Brinzolamide—Breast disorder—Docetaxel—skin cancer	0.000834	0.00161	CcSEcCtD
Brinzolamide—Discomfort—Bleomycin—skin cancer	0.000834	0.00161	CcSEcCtD
Brinzolamide—Malaise—Dactinomycin—skin cancer	0.000834	0.0016	CcSEcCtD
Brinzolamide—Nasopharyngitis—Docetaxel—skin cancer	0.000826	0.00159	CcSEcCtD
Brinzolamide—Dysgeusia—Temozolomide—skin cancer	0.000819	0.00158	CcSEcCtD
Brinzolamide—Asthenia—Imiquimod—skin cancer	0.000817	0.00157	CcSEcCtD
Brinzolamide—Back pain—Temozolomide—skin cancer	0.000809	0.00156	CcSEcCtD
Brinzolamide—Pruritus—Imiquimod—skin cancer	0.000806	0.00155	CcSEcCtD
Brinzolamide—Infection—Bleomycin—skin cancer	0.000804	0.00155	CcSEcCtD
Brinzolamide—CA2—lymph node—skin cancer	0.000795	0.00681	CbGeAlD
Brinzolamide—Nausea—Vemurafenib—skin cancer	0.000793	0.00153	CcSEcCtD
Brinzolamide—Arrhythmia—Fluorouracil—skin cancer	0.000791	0.00152	CcSEcCtD
Brinzolamide—Vision blurred—Temozolomide—skin cancer	0.000788	0.00152	CcSEcCtD
Brinzolamide—Myalgia—Dactinomycin—skin cancer	0.000787	0.00152	CcSEcCtD
Brinzolamide—Tremor—Temozolomide—skin cancer	0.000783	0.00151	CcSEcCtD
Brinzolamide—Alopecia—Fluorouracil—skin cancer	0.000782	0.00151	CcSEcCtD
Brinzolamide—Diarrhoea—Imiquimod—skin cancer	0.000779	0.0015	CcSEcCtD
Brinzolamide—Discomfort—Dactinomycin—skin cancer	0.000778	0.0015	CcSEcCtD
Brinzolamide—Angina pectoris—Docetaxel—skin cancer	0.000777	0.0015	CcSEcCtD
Brinzolamide—Ill-defined disorder—Temozolomide—skin cancer	0.000776	0.00149	CcSEcCtD
Brinzolamide—Erythema—Fluorouracil—skin cancer	0.00077	0.00148	CcSEcCtD
Brinzolamide—Agitation—Temozolomide—skin cancer	0.000768	0.00148	CcSEcCtD
Brinzolamide—Hypotension—Bleomycin—skin cancer	0.000756	0.00146	CcSEcCtD
Brinzolamide—Malaise—Temozolomide—skin cancer	0.000754	0.00145	CcSEcCtD
Brinzolamide—Dizziness—Imiquimod—skin cancer	0.000753	0.00145	CcSEcCtD
Brinzolamide—Vertigo—Temozolomide—skin cancer	0.000751	0.00145	CcSEcCtD
Brinzolamide—Infection—Dactinomycin—skin cancer	0.00075	0.00144	CcSEcCtD
Brinzolamide—Palpitations—Temozolomide—skin cancer	0.000739	0.00142	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000737	0.00142	CcSEcCtD
Brinzolamide—Cough—Temozolomide—skin cancer	0.00073	0.0014	CcSEcCtD
Brinzolamide—Paraesthesia—Bleomycin—skin cancer	0.000727	0.0014	CcSEcCtD
Brinzolamide—Vision blurred—Fluorouracil—skin cancer	0.000726	0.0014	CcSEcCtD
Brinzolamide—Vomiting—Imiquimod—skin cancer	0.000724	0.00139	CcSEcCtD
Brinzolamide—Hypertension—Temozolomide—skin cancer	0.000722	0.00139	CcSEcCtD
Brinzolamide—Dyspnoea—Bleomycin—skin cancer	0.000721	0.00139	CcSEcCtD
Brinzolamide—Rash—Imiquimod—skin cancer	0.000718	0.00138	CcSEcCtD
Brinzolamide—Dermatitis—Imiquimod—skin cancer	0.000717	0.00138	CcSEcCtD
Brinzolamide—Headache—Imiquimod—skin cancer	0.000713	0.00137	CcSEcCtD
Brinzolamide—Myalgia—Temozolomide—skin cancer	0.000712	0.00137	CcSEcCtD
Brinzolamide—Arthralgia—Temozolomide—skin cancer	0.000712	0.00137	CcSEcCtD
Brinzolamide—Infestation—Docetaxel—skin cancer	0.000712	0.00137	CcSEcCtD
Brinzolamide—Infestation NOS—Docetaxel—skin cancer	0.000712	0.00137	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000707	0.00136	CcSEcCtD
Brinzolamide—Discomfort—Temozolomide—skin cancer	0.000703	0.00135	CcSEcCtD
Brinzolamide—Decreased appetite—Bleomycin—skin cancer	0.000703	0.00135	CcSEcCtD
Brinzolamide—Dry mouth—Temozolomide—skin cancer	0.000696	0.00134	CcSEcCtD
Brinzolamide—Pain—Bleomycin—skin cancer	0.000692	0.00133	CcSEcCtD
Brinzolamide—Conjunctivitis—Docetaxel—skin cancer	0.000692	0.00133	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000687	0.00132	CcSEcCtD
Brinzolamide—Infection—Temozolomide—skin cancer	0.000678	0.00131	CcSEcCtD
Brinzolamide—Nausea—Imiquimod—skin cancer	0.000676	0.0013	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Docetaxel—skin cancer	0.000673	0.0013	CcSEcCtD
Brinzolamide—Epistaxis—Docetaxel—skin cancer	0.000671	0.00129	CcSEcCtD
Brinzolamide—Nervous system disorder—Temozolomide—skin cancer	0.000669	0.00129	CcSEcCtD
Brinzolamide—Feeling abnormal—Bleomycin—skin cancer	0.000667	0.00128	CcSEcCtD
Brinzolamide—Skin disorder—Temozolomide—skin cancer	0.000663	0.00128	CcSEcCtD
Brinzolamide—Chest pain—Fluorouracil—skin cancer	0.000656	0.00126	CcSEcCtD
Brinzolamide—Myalgia—Fluorouracil—skin cancer	0.000656	0.00126	CcSEcCtD
Brinzolamide—Decreased appetite—Dactinomycin—skin cancer	0.000656	0.00126	CcSEcCtD
Brinzolamide—Fatigue—Dactinomycin—skin cancer	0.000651	0.00125	CcSEcCtD
Brinzolamide—Discomfort—Fluorouracil—skin cancer	0.000648	0.00125	CcSEcCtD
Brinzolamide—Pain—Dactinomycin—skin cancer	0.000645	0.00124	CcSEcCtD
Brinzolamide—Urticaria—Bleomycin—skin cancer	0.000643	0.00124	CcSEcCtD
Brinzolamide—Rhinitis—Docetaxel—skin cancer	0.00064	0.00123	CcSEcCtD
Brinzolamide—Hypoaesthesia—Docetaxel—skin cancer	0.000636	0.00122	CcSEcCtD
Brinzolamide—Pharyngitis—Docetaxel—skin cancer	0.000634	0.00122	CcSEcCtD
Brinzolamide—Urinary tract disorder—Docetaxel—skin cancer	0.000631	0.00121	CcSEcCtD
Brinzolamide—Oedema peripheral—Docetaxel—skin cancer	0.000629	0.00121	CcSEcCtD
Brinzolamide—Connective tissue disorder—Docetaxel—skin cancer	0.000628	0.00121	CcSEcCtD
Brinzolamide—Urethral disorder—Docetaxel—skin cancer	0.000626	0.00121	CcSEcCtD
Brinzolamide—Infection—Fluorouracil—skin cancer	0.000625	0.0012	CcSEcCtD
Brinzolamide—Feeling abnormal—Dactinomycin—skin cancer	0.000622	0.0012	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000622	0.0012	CcSEcCtD
Brinzolamide—Insomnia—Temozolomide—skin cancer	0.000617	0.00119	CcSEcCtD
Brinzolamide—Nervous system disorder—Fluorouracil—skin cancer	0.000617	0.00119	CcSEcCtD
Brinzolamide—Visual impairment—Docetaxel—skin cancer	0.000616	0.00119	CcSEcCtD
Brinzolamide—Tachycardia—Fluorouracil—skin cancer	0.000614	0.00118	CcSEcCtD
Brinzolamide—Paraesthesia—Temozolomide—skin cancer	0.000613	0.00118	CcSEcCtD
Brinzolamide—Dyspnoea—Temozolomide—skin cancer	0.000608	0.00117	CcSEcCtD
Brinzolamide—Somnolence—Temozolomide—skin cancer	0.000607	0.00117	CcSEcCtD
Brinzolamide—Dyspepsia—Temozolomide—skin cancer	0.000601	0.00116	CcSEcCtD
Brinzolamide—Eye disorder—Docetaxel—skin cancer	0.000597	0.00115	CcSEcCtD
Brinzolamide—Hypersensitivity—Bleomycin—skin cancer	0.000596	0.00115	CcSEcCtD
Brinzolamide—Decreased appetite—Temozolomide—skin cancer	0.000593	0.00114	CcSEcCtD
Brinzolamide—Cardiac disorder—Docetaxel—skin cancer	0.000593	0.00114	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000589	0.00113	CcSEcCtD
Brinzolamide—Fatigue—Temozolomide—skin cancer	0.000588	0.00113	CcSEcCtD
Brinzolamide—Hypotension—Fluorouracil—skin cancer	0.000588	0.00113	CcSEcCtD
Brinzolamide—Pain—Temozolomide—skin cancer	0.000584	0.00112	CcSEcCtD
Brinzolamide—Asthenia—Bleomycin—skin cancer	0.00058	0.00112	CcSEcCtD
Brinzolamide—Angiopathy—Docetaxel—skin cancer	0.00058	0.00112	CcSEcCtD
Brinzolamide—Immune system disorder—Docetaxel—skin cancer	0.000577	0.00111	CcSEcCtD
Brinzolamide—Mediastinal disorder—Docetaxel—skin cancer	0.000576	0.00111	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000573	0.0011	CcSEcCtD
Brinzolamide—Pruritus—Bleomycin—skin cancer	0.000572	0.0011	CcSEcCtD
Brinzolamide—Arrhythmia—Docetaxel—skin cancer	0.000571	0.0011	CcSEcCtD
Brinzolamide—Insomnia—Fluorouracil—skin cancer	0.000569	0.00109	CcSEcCtD
Brinzolamide—Paraesthesia—Fluorouracil—skin cancer	0.000565	0.00109	CcSEcCtD
Brinzolamide—Alopecia—Docetaxel—skin cancer	0.000565	0.00109	CcSEcCtD
Brinzolamide—Feeling abnormal—Temozolomide—skin cancer	0.000562	0.00108	CcSEcCtD
Brinzolamide—Dyspnoea—Fluorouracil—skin cancer	0.000561	0.00108	CcSEcCtD
Brinzolamide—Mental disorder—Docetaxel—skin cancer	0.00056	0.00108	CcSEcCtD
Brinzolamide—Somnolence—Fluorouracil—skin cancer	0.000559	0.00108	CcSEcCtD
Brinzolamide—Malnutrition—Docetaxel—skin cancer	0.000556	0.00107	CcSEcCtD
Brinzolamide—Erythema—Docetaxel—skin cancer	0.000556	0.00107	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—skin cancer	0.000556	0.00107	CcSEcCtD
Brinzolamide—Dyspepsia—Fluorouracil—skin cancer	0.000554	0.00107	CcSEcCtD
Brinzolamide—Decreased appetite—Fluorouracil—skin cancer	0.000547	0.00105	CcSEcCtD
Brinzolamide—Dysgeusia—Docetaxel—skin cancer	0.000545	0.00105	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000543	0.00105	CcSEcCtD
Brinzolamide—Urticaria—Temozolomide—skin cancer	0.000542	0.00104	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—skin cancer	0.000541	0.00104	CcSEcCtD
Brinzolamide—Back pain—Docetaxel—skin cancer	0.000538	0.00104	CcSEcCtD
Brinzolamide—Pain—Fluorouracil—skin cancer	0.000538	0.00104	CcSEcCtD
Brinzolamide—Muscle spasms—Docetaxel—skin cancer	0.000535	0.00103	CcSEcCtD
Brinzolamide—Feeling abnormal—Fluorouracil—skin cancer	0.000518	0.000997	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—skin cancer	0.000516	0.000994	CcSEcCtD
Brinzolamide—Vomiting—Bleomycin—skin cancer	0.000514	0.00099	CcSEcCtD
Brinzolamide—Rash—Bleomycin—skin cancer	0.00051	0.000982	CcSEcCtD
Brinzolamide—Dermatitis—Bleomycin—skin cancer	0.00051	0.000981	CcSEcCtD
Brinzolamide—Hypersensitivity—Temozolomide—skin cancer	0.000503	0.000968	CcSEcCtD
Brinzolamide—Urticaria—Fluorouracil—skin cancer	0.0005	0.000962	CcSEcCtD
Brinzolamide—Palpitations—Docetaxel—skin cancer	0.000491	0.000946	CcSEcCtD
Brinzolamide—Asthenia—Temozolomide—skin cancer	0.00049	0.000943	CcSEcCtD
Brinzolamide—Cough—Docetaxel—skin cancer	0.000485	0.000934	CcSEcCtD
Brinzolamide—Pruritus—Temozolomide—skin cancer	0.000483	0.000929	CcSEcCtD
Brinzolamide—Nausea—Bleomycin—skin cancer	0.000481	0.000925	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—skin cancer	0.00048	0.000924	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—skin cancer	0.00048	0.000924	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—skin cancer	0.000476	0.000916	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—skin cancer	0.000473	0.000911	CcSEcCtD
Brinzolamide—Myalgia—Docetaxel—skin cancer	0.000473	0.000911	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—skin cancer	0.000473	0.000911	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00047	0.000905	CcSEcCtD
Brinzolamide—Diarrhoea—Temozolomide—skin cancer	0.000467	0.000899	CcSEcCtD
Brinzolamide—Hypersensitivity—Fluorouracil—skin cancer	0.000463	0.000892	CcSEcCtD
Brinzolamide—Dry mouth—Docetaxel—skin cancer	0.000463	0.000891	CcSEcCtD
Brinzolamide—Dizziness—Temozolomide—skin cancer	0.000451	0.000869	CcSEcCtD
Brinzolamide—Infection—Docetaxel—skin cancer	0.000451	0.000868	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—skin cancer	0.000448	0.000863	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—skin cancer	0.000445	0.000857	CcSEcCtD
Brinzolamide—Pruritus—Fluorouracil—skin cancer	0.000445	0.000856	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—skin cancer	0.000443	0.000853	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—skin cancer	0.000441	0.000849	CcSEcCtD
Brinzolamide—Vomiting—Temozolomide—skin cancer	0.000434	0.000835	CcSEcCtD
Brinzolamide—Rash—Temozolomide—skin cancer	0.00043	0.000828	CcSEcCtD
Brinzolamide—Diarrhoea—Fluorouracil—skin cancer	0.00043	0.000828	CcSEcCtD
Brinzolamide—Dermatitis—Temozolomide—skin cancer	0.00043	0.000828	CcSEcCtD
Brinzolamide—Headache—Temozolomide—skin cancer	0.000428	0.000823	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—skin cancer	0.000424	0.000816	CcSEcCtD
Brinzolamide—Dizziness—Fluorouracil—skin cancer	0.000416	0.0008	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000414	0.000796	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—skin cancer	0.000411	0.00079	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—skin cancer	0.000408	0.000784	CcSEcCtD
Brinzolamide—Nausea—Temozolomide—skin cancer	0.000405	0.00078	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—skin cancer	0.000405	0.000779	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—skin cancer	0.000403	0.000777	CcSEcCtD
Brinzolamide—Vomiting—Fluorouracil—skin cancer	0.0004	0.00077	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—skin cancer	0.0004	0.000769	CcSEcCtD
Brinzolamide—Rash—Fluorouracil—skin cancer	0.000396	0.000763	CcSEcCtD
Brinzolamide—Dermatitis—Fluorouracil—skin cancer	0.000396	0.000763	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—skin cancer	0.000395	0.000759	CcSEcCtD
Brinzolamide—Headache—Fluorouracil—skin cancer	0.000394	0.000758	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000392	0.000754	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—skin cancer	0.000391	0.000753	CcSEcCtD
Brinzolamide—Pain—Docetaxel—skin cancer	0.000388	0.000747	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—skin cancer	0.000374	0.00072	CcSEcCtD
Brinzolamide—Nausea—Fluorouracil—skin cancer	0.000374	0.000719	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—skin cancer	0.000334	0.000644	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—skin cancer	0.000326	0.000627	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—skin cancer	0.000321	0.000618	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—skin cancer	0.000311	0.000598	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—skin cancer	0.0003	0.000578	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—skin cancer	0.000289	0.000555	CcSEcCtD
Brinzolamide—Rash—Docetaxel—skin cancer	0.000286	0.000551	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—skin cancer	0.000286	0.00055	CcSEcCtD
Brinzolamide—Headache—Docetaxel—skin cancer	0.000284	0.000547	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—skin cancer	0.00027	0.000519	CcSEcCtD
